CGRP ligand drugs for Migraine
3 tracked CGRP ligand drugs in the Migraine race. The class explanation lives on the CGRP ligand page; the full indication pipeline across every mechanism is on the Migraine page.
3 approved / phase 4
Head-to-head evidence: Eptinezumab (Vyepti) vs Fremanezumab (Ajovy) · Eptinezumab (Vyepti) vs Galcanezumab (Emgality) · Fremanezumab (Ajovy) vs Galcanezumab (Emgality)